Radium 223 in Castrate Resistant Prostate Cancer Bone Metastases

NCT02135484 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Alpharadin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]